Risk factors of contrast‑induced nephropathy in patients with STEMI and pump failure undergoing percutaneous coronary intervention

Chen,Hongwu; Yu,Xiaofan; Ma,Likun

doi:10.3892/etm.2020.9572

Risk factors of contrast‑induced nephropathy in patients with STEMI and pump failure undergoing percutaneous coronary intervention

Authors:
- Hongwu Chen
- Xiaofan Yu
- Likun Ma
View Affiliations

Affiliations: Department of Cardiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of the University of Science and Technology of China (USTC), USTC, Hefei, Anhui 230001, P.R. China
Published online on: December 14, 2020 https://doi.org/10.3892/etm.2020.9572
Article Number: 140
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Risk factors associated with the development of contrast‑induced nephropathy (CIN) remain poorly defined in patients with ST‑elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). The present study was designed to assess the association between the Killip grade and the development of CIN in patients with STEMI and pump failure undergoing PCI. Data were retrospectively collected from the records of patients with STEMI and pump failure from the Chinese Society of Cardiology and American Heart Association database. A total of 7,471 patients were analyzed, including 5,521 patients with Killip grade II, 878 with Killip III and 1,072 with Killip IV pump failure. Patients were classified into two groups: Those undergoing primary PCI (PPCI; n=5,063) and those undergoing elective PCI (EPCI; n=2,408). Patients in the PPCI group had higher cardiac arrest rates, lower blood pressure and higher cholesterol levels as compared to the EPCI group. There was a statistically significant difference in the rates of CIN with Killip II pump failure in the PPCI group as compared to the EPCI group, but not in those with Killip III and VI pump failure. Logistic regression analysis indicated that the Killip classification is a risk predictor for post‑PCI CIN. The present results indicated a positive association between the Killip grade and post‑PCI CIN in patients with STEMI and pump failure. In addition, patients with STEMI and Killip grade II pump failure were at a higher risk of PCI after PPCI as compared to EPCI. Further prospective studies are required to confirm the present results.

View Figures

View References

1	Keeley EC, Boura JA and Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet. 361:13–20. 2003.PubMed/NCBI View Article : Google Scholar
2	Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E, Aydogdu S, Akpek M and Kaya MG: Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol. 110:1405–1410. 2012.PubMed/NCBI View Article : Google Scholar
3	De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, et al: Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation: Drug-eluting vs bare-metal stents in primary angioplasty: A pooled patient-level meta-analysis of randomized trials. Arch Intern Med. 172:611–622. 2012.PubMed/NCBI View Article : Google Scholar
4	Jukema JW, Verschuren JJW, Ahmed TAN and Quax PHA: Restenosis after PCI. Part 1: Pathophysiology and risk factors. Nat Rev Cardiol. 9:53–62. 2011.PubMed/NCBI View Article : Google Scholar
5	Li J-J, Ren Y, Chen K-J, Yeung AC, Xu B, Ruan XM, Yang YJ, Chen JL and Gao RL: Impact of C-reactive protein on in-stent restenosis: A meta-analysis. Tex Heart Inst J. 37:49–57. 2010.PubMed/NCBI
6	Bolca O, Güngör B, Özcan KS, Karadeniz FÖ, Sungur A, Köroğlu B, Bakhshyaliyev N, Yelgeç NS, Karataş B, İpek G, et al: The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI. Coron Artery Dis. 26:402–408. 2015.PubMed/NCBI View Article : Google Scholar
7	AlFaleh HF, Alsuwaida AO, Ullah A, Hersi A, AlHabib KF, AlNemer K, AlSaif S, Taraben A, Kashour T, Balghith MA, et al: The prognostic impact of in-hospital worsening of renal function in patients with acute coronary syndrome. Int J Cardiol. 167:866–870. 2013.PubMed/NCBI View Article : Google Scholar
8	Amin AP, Spertus JA, Reid KJ, Lan X, Buchanan DM, Decker C and Masoudi FA: The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. Am Heart J. 160:1065–1071. 2010.PubMed/NCBI View Article : Google Scholar
9	Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, Agmon Y, Markiewicz W and Aronson D: Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 150:330–337. 2005.PubMed/NCBI View Article : Google Scholar
10	Stefanini GG, Taniwaki M, Kalesan B, Räber L, Stortecky S, Pilgrim T, Onuma Y, Silber S, Serruys PW, Meier B, et al: The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents. PLoS One. 9(e106450)2014.PubMed/NCBI View Article : Google Scholar
11	Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL and Kastrati A: Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 100:153–159. 2014.PubMed/NCBI View Article : Google Scholar
12	Best PJM, Berger PB, Davis BR, Grines CL, Sadeghi HM, Williams BA, Willerson JT, Granett JR and Holmes DR Jr: PRESTO Investigators. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial. J Am Coll Cardiol. 44:1786–1791. 2004.PubMed/NCBI View Article : Google Scholar
13	Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F and Bartorelli AL: Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 44:1780–1785. 2004.PubMed/NCBI View Article : Google Scholar
14	Hao Y, Liu J, Liu J, Smith SC Jr, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, et al: CCC-ACS Investigators: Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. Am Heart J. 179:107–115. 2016.PubMed/NCBI View Article : Google Scholar
15	Shen W and Gao R: Chinese Society of Cardiology. Guideline for diagnosis and treatment of patients with ST-elevation myocardial infarction. China J Cardiol. 38:675–690. 2010.PubMed/NCBI
16	Killip T III and Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 20:457–464. 1967.PubMed/NCBI View Article : Google Scholar
17	Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA and Topol EJ: Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: The enduring value of Killip classification. JAMA. 290:2174–2181. 2003.PubMed/NCBI View Article : Google Scholar
18	Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Nagashima M, Fujii S, Koyanagi R, Ogawa H, Hagiwara N, Haze K, et al: HIJC Investigators: Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: Data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry. Circ J. 71:1354–1359. 2007.PubMed/NCBI View Article : Google Scholar
19	Halkin A, Mehran R, Casey CW, Gordon P, Matthews R, Wilson BH, Leon MB, Russell ME, Ellis SG and Stone GW: Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV Trial. Am Heart J. 150:1163–1170. 2005.PubMed/NCBI View Article : Google Scholar
20	Wang C-H, Zhang S-Y, Fang Q, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY and Xie HZ: Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction. Am J Med Sci. 349:413–420. 2015.PubMed/NCBI View Article : Google Scholar
21	Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J, Lv AK, Zhang JS and Shen WF: Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention. Int J Cardiol. 136:72–79. 2009.PubMed/NCBI View Article : Google Scholar
22	Garg P, Charytan DM, Novack L, Cutlip DE, Popma JJ, Moses J, Leon MB, Schofer J, Breithardt G, Schampaert E, et al: Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). Am J Cardiol. 106:1436–1442. 2010.PubMed/NCBI View Article : Google Scholar
23	Sahin I, Gungor B, Can MM, Avci II, Guler GB, Okuyan E, Biter H, Yildiz SS, Ayca B, Satilmis S, et al: Lower blood vitamin D levels are associated with an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography. Can J Cardiol. 30:428–433. 2014.PubMed/NCBI View Article : Google Scholar
24	Seyfarth M, Kastrati A, Mann JFE, Ndrepepa G, Byrne RA, Schulz S, Mehilli J and Schömig A: Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention. Am J Kidney Dis. 54:830–839. 2009.PubMed/NCBI View Article : Google Scholar
25	Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A, Vassanelli C, Campolo L, Martuscelli E and Tommasini G: Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol. 32:90–96. 1998.PubMed/NCBI View Article : Google Scholar
26	Sahin I, Karabulut A, Avci II, Okuyan E, Biter HI, Yildiz SS, Can MM, Gungor B, Dinckal M and Serebruany V: Contribution of platelets indices in the development of contrast-induced nephropathy. Blood Coagul Fibrinolysis. 26:246–249. 2015.PubMed/NCBI View Article : Google Scholar
27	Börekçi A, Gür M, Türkoğlu C, Çaylı M, Selek Ş, Kaypaklı O, Uçar H, Coşkun M, Şeker T, Koç M, et al: Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 66:339–345. 2015.PubMed/NCBI View Article : Google Scholar
28	Mizuguchi Y, Shibutani H, Hashimoto S, Yamada T, Taniguchi N, Nakajima S, Hata T and Takahashi A: Examination of the appropriate timing of reperfusion therapy for recent myocardial infarction: A Japanese single-center retrospective study. Indian Heart J. 70:4–9. 2018.PubMed/NCBI View Article : Google Scholar
29	Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, Boulos M, Kapeliovich MR, Beyar R, Nikolsky E, et al: Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit? J Am Heart Assoc. 6(6)2017.PubMed/NCBI View Article : Google Scholar
30	Velibey Y, Tanik O, Oz A, Guvenc TS, Kalenderoglu K, Gumusdag A, Guzelburc O, Tekkesin AI, Uzun AO, Alper AT, et al: Off-Hour Primary Percutaneous Coronary Angioplasty Does Not Affect Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction. Angiology. 68:807–815. 2017.PubMed/NCBI View Article : Google Scholar
31	Marrón B, Ruiz E, Fernández C, Almeida P, Horcajada C, Navarro F and Caramelo C: Systemic and renal effects of preventing contrast nephrotoxicity with isotonic (0.9%) and hypotonic (0.45%) saline. Rev Esp Cardiol. 60:1018–1025. 2007.PubMed/NCBI View Article : Google Scholar : (In Spanish).